EXTENDICARE INC. Logo
CA30224T8639
A1JZ4L
EXE.TO

EXTENDICARE INC.

Prognoza

Kupuj
  0
Trzymaj
  1
Sprzedaj
  0

Dyskusje w społeczności

  • Monatszahler mit guter Dividende?

    Sylvia Sylvia V w Schnack

    3 44

  • Extendicare reports strong Q2 growth as acquisitions drive revenue and EBITDA

    Extendicare posted Q2 revenue up 59.4% to C$611 million and adjusted EBITDA up 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, acquired Revera homes and Closing the Gap. CBI added C$145.7 million of revenue and C$18.5 million of adjusted EBITDA; management expects a methodical 18–24 month integration delivering C$7.4 million of annual cost synergies. The company refinanced debt, lowering its weighted-average interest rate to 4.4% and reducing pro forma leverage to about 2.5x, while advancing six long-term-care redevelopment projects and planning to add 832 beds across four openings in 2027. Home health volumes rose sharply but margins were modestly pressured by investment in technology and support functions; management expects longer-term volume growth of about 6–8% annually. » Więcej na finance.yahoo.com


  • Extendicare beats revenue forecasts, misses earnings and stock falls

    Extendicare reported second-quarter 2026 revenue of 611 million CAD (+59.4%), well above expectations, while earnings of $0.319 per share missed the analyst estimate of $0.34. Adjusted EBITDA rose to 68.3 million CAD and adjusted results improved, but transaction, integration and refinancing costs weighed on net income. Management says the CBI integration is still in its early stages and expects 18–24 months for full integration, along with further investments in long-term care and home health. The stock fell about 8.7% in after-hours trading to $31.22 as investors put more weight on the earnings miss and near-term margin risks than on revenue growth. » Więcej na de.investing.com


  • Extendicare beats Q1 2026 earnings expectations by a wide margin and stock rises

    Extendicare reported Q1 2026 EPS of 0.422 CAD, surpassing the analyst estimate of 0.2033 CAD by 107.6%. Revenue was 465.2 million CAD (+24.2% y/y), slightly below expectations, while adjusted EBITDA and AFFO rose markedly. Strong volume growth in the home-healthcare segment (32.7%) was driven by acquisitions and organic growth; the acquisition of CBI Home Health was completed. The stock climbed 10.84% after hours to 33.44 CAD; management continues to reaffirm ambitious profit and revenue guidance for 2026/2027. » Więcej na de.investing.com


  • Extendicare: stronger adjusted EBITDA from boom in home care, CBI acquisition creates national platform

    Extendicare reported adjusted EBITDA of $44.2m for Q1 2026 (+52.2% year‑over‑year) and strong operational momentum driven by rapid volume growth in home care. Revenue rose to CAD 465.2m (below consensus), EPS materially beat expectations; AFFO per share climbed 55.9% to $0.276. In early April Extendicare completed the $570m acquisition of CBI Home Health, creating the leading home‑care platform in Canada and adding roughly $61.9m of adjusted EBITDA and 8,500 employees. To finance the deal the company issued $450m of unsecured senior notes, improving its capital structure; pro‑forma leverage is about 2.8x EBITDA. Management cites integration, labour shortages and timing of government funding as the main execution risks. » Więcej na de.investing.com


  • Extendicare completes acquisition of CBI Home Health for $570 million

    Extendicare, through its subsidiary ParaMed, has completed the cash acquisition of CBI Home Health and related units for $570.0 million; estimated lease liabilities of about $13.6 million are additional. The transaction represents roughly 2% of Extendicare’s market capitalization and was funded by net proceeds from a private placement (≈$191.5 million), borrowings under senior secured credit facilities (≈$308.2 million) and cash. According to the data, the company reports a moderate leverage ratio of 0.27; Extendicare says the acquisition geographically and clinically complements its home‑health platform. » Więcej na de.investing.com

W 2026 roku EXTENDICARE INC. wypłaciła już 0,30 € dywidend. Ostatnia wypłata nastąpiła w listopad.

Dane finansowe

W ostatnim kwartale EXTENDICARE INC. osiągnęła przychody w wysokości 389,35 mln € i zysk netto w wysokości 21,21 mln €

(EUR) wrzesień 2026
YoY
Przychody 389,35 mln 44,50%
Zysk brutto 44,57 mln 30,28%
Zysk netto 21,21 mln 43,67%
EBITDA 44,47 mln 49,68%

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
1,6 mld €
Liczba akcji
88,37 mln
Maksimum/minimum z 52 tygodni
24,77 € - 13,02 €
Stopa dywidendy
1,83%
Dywidendy TTM
0,35 €
Następna dywidenda
0,028 €
Beta
1,16
C/Z (PE Ratio)
20,46
PEG (PEG Ratio)
0,99
C/WK (PB Ratio)
6,38
C/S (PS Ratio)
1,26

Profil spółki

Extendicare Inc. poprzez swoje spółki zależne świadczy opiekę i usługi dla seniorów w Kanadzie. Firma oferuje usługi opieki długoterminowej (LTC); usługi domów opieki dla osób starszych typu retirement living; a także usługi opieki domowej, takie jak opieka pielęgniarska, terapia zajęciowa, fizjoterapia i logopedia oraz pomoc w codziennych czynnościach, a także usługi kontraktowe i doradcze dla podmiotów trzecich. Prowadzi sieć 119 domów LTC i społeczności seniorów, a także działalność w zakresie opieki domowej pod markami Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist oraz SGP Purchasing Partner Network. Extendicare Inc. została założona w 1968 roku i ma siedzibę w Markham w Kanadzie.

Nazwa
EXTENDICARE INC.
CEO
Michael R. Guerriere
Siedziba Markham, on
Kanada
Strona internetowa
Sektor
Ochrona zdrowia
Branża
Ochrona zdrowia: świadczeniodawcy i usługi
Debiut giełdowy
24.09.2012
Pracownicy 23 500

Symbole giełdowe

Giełda Symbol
Toronto Stock Exchange
EXE.TO
Pnk
EXETF
London Stock Exchange
0S9E.L
Frankfurt
5XE.F
Düsseldorf
5XE.DU
London
0S9E.L
München
5XE.MU
🍪

Parqet  używa plików cookie. Dowiedz się więcej